BALLARD PARTNERS

Lobbying for BIOSTEM TECHNOLOGIES · Regenerative medicine company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Florida · $120,000.00 income · posted Jan 12, 2026

Lobbying activity 1

Medicare/Medicaid

Advocated for medicare reimbursement for skin substitutes that are used to heal wounds caused from diabetes.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.